VINCRISTINE SULFATE
Stage II Enteropathy-Associated T-Cell Lymphoma
University of NebraskaSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
21 Active assets in the Stage II Enteropathy-Associated T-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Eric Jacobsen, MD | Phase 4 | BBB |
Inno-206 Eric Jacobsen, MD | Phase 4 | BBB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 4 | BBB |
PREDNISONE TABLETS Eric Jacobsen, MD | Phase 4 | BB |
Ifosfamide Shandong Provincial Hospital | Phase 4 | BB |
View all 36 →
Same molecule, other indications
VINCRISTINE SULFATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →